Voyager Therapeutics Aktie
WKN DE: A143XJ / ISIN: US92915B1061
03.03.2025 14:41:12
|
Voyager Therapeutics Reports Positive Data From Single Ascending Dose Study Of VY7523
(RTTNews) - Voyager Therapeutics, Inc. (VYGR) Monday announced positive topline data from its single ascending dose (SAD) study of VY7523 developed for the treatment of Alzheimers disease (AD).
The study was to evaluate safety, tolerability, and dose-proportional pharmacokinetics (PK) of VY7523 in healthy volunteers.
Voyager has initiated a multiple ascending dose (MAD) study of VY7523 in patients with early AD with data expected in the second half of 2026.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Voyager Therapeutics Incmehr Nachrichten
10.03.25 |
Ausblick: Voyager Therapeutics gewährt Anlegern Blick in die Bücher (finanzen.net) |
Analysen zu Voyager Therapeutics Incmehr Analysen
Aktien in diesem Artikel
Voyager Therapeutics Inc | 2,98 | -2,43% |
|